0001493152-23-024326 Sample Contracts

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • July 12th, 2023 • Marizyme, Inc. • Pharmaceutical preparations

This Registration Rights Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is made and entered into as of July 10, 2023 among Marizyme, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

AutoNDA by SimpleDocs
Contract
Marizyme, Inc. • July 12th, 2023 • Pharmaceutical preparations

THIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.

UNIT PURCHASE AGREEMENT
Unit Purchase Agreement • July 12th, 2023 • Marizyme, Inc. • Pharmaceutical preparations • Nevada

This Unit Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of July 10, 2023, by and among Marizyme, Inc., a Nevada corporation (the “Company”), and each investor identified on Appendix A hereto (each, including its successors and assigns, an “Investor” and collectively, the “Investors”).

AMENDMENT TO REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • July 12th, 2023 • Marizyme, Inc. • Pharmaceutical preparations

This AMENDMENT TO REGISTRATION RIGHTS AGREEMENT (this “Amendment”) is made and entered into as of July 6, 2023, by and between Marizyme, Inc., a Nevada corporation (the “Company”) and each of the several investors signatory hereto (each such investor, an “Investor” and, collectively, the “Investors”).

Time is Money Join Law Insider Premium to draft better contracts faster.